Cargando…
EPH51 Associations between Psychiatric Disorders and COVID-19 in Japan: Results from the Life Study
Autores principales: | Murata, F, Maeda, M, Fukuda, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232761/ http://dx.doi.org/10.1016/j.jval.2022.04.804 |
Ejemplares similares
-
Acute and delayed psychiatric sequelae among patients hospitalised with COVID-19: a cohort study using LIFE study data
por: Murata, Fumiko, et al.
Publicado: (2022) -
Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study
por: Fukuda, Haruhisa, et al.
Publicado: (2023) -
Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer’s Disease Patients in Japan: LIFE Study
por: Fukuda, Haruhisa, et al.
Publicado: (2022) -
Survey of psychiatric symptoms among inpatients with COVID-19 using the Diagnosis Procedure Combination data and medical records in Japan
por: Nakao, Tomohiro, et al.
Publicado: (2023) -
Changes in percutaneous coronary intervention practice in Japan during the COVID‐19 outbreak: LIFE Study
por: Maeda, Megumi, et al.
Publicado: (2021)